Adjuvant and neoadjuvant therapy in non-small cell lung cancer
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 32, S9-S15
- https://doi.org/10.1053/j.seminoncol.2005.02.005
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Randomized Study of Adjuvant Chemotherapy for Completely Resected Stage I, II, or IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 2003
- A Randomized Trial of Postoperative Adjuvant Therapy in Patients with Completely Resected Stage II or IIIa Non–Small-Cell Lung CancerNew England Journal of Medicine, 2000
- Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancerThe Annals of Thoracic Surgery, 1997
- Regional Lymph Node Classification for Lung Cancer StagingChest, 1997
- Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patientsCancer, 1995
- Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancerThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Postoperative adjuvant chemotherapy in non‐small cell lung cancer: Prognostic value of DNA ploidy and postrecurrent survivalJournal of Surgical Oncology, 1991
- The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. The Lung Cancer Study Group.Journal of Clinical Oncology, 1988
- Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.Journal of Clinical Oncology, 1986